Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis

D G Remick1, S J Garg, D E Newcomb

  • 1Department of Pathology, University of Michigan, Ann Arbor 48109-0602, USA.

Critical Care Medicine
|May 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemokines mediate ethanol-induced exacerbations of murine cockroach allergen asthma.

Clinical and experimental immunology·2013
Same author

Whole-blood assays for cytokine production.

Methods in molecular medicine·2011
Same author

Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction.

Bone marrow transplantation·2009
Same author

Anti-tumor necrosis factor-alpha antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2006
Same author

Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo.

Cell biology and toxicology·2004
Same author

Reproducibility of a novel model of murine asthma-like pulmonary inflammation.

Clinical and experimental immunology·2004

Exogenous interleukin-10 (IL-10) did not improve survival or reduce inflammation in a mouse model of sepsis. This study found no benefit of IL-10 in treating sepsis induced by cecal ligation and puncture.

Area of Science:

  • Immunology
  • Sepsis research
  • Animal models of disease

Background:

  • Sepsis is a life-threatening condition characterized by a dysregulated host response to infection.
  • Interleukin-10 (IL-10) is a cytokine with known anti-inflammatory and immunosuppressive properties.
  • The potential therapeutic role of IL-10 in sepsis remains an area of investigation.

Purpose of the Study:

  • To investigate the efficacy of exogenous interleukin-10 (IL-10) in reducing the morbidity and mortality associated with sepsis.
  • To evaluate the impact of IL-10 on key inflammatory markers and physiological parameters in a murine model of sepsis.

Main Methods:

  • A prospective, randomized, controlled study was conducted using adult female Balb/c mice.
  • Sepsis was induced via cecal ligation and puncture (CLP), followed by administration of triple antibiotics.

Related Experiment Videos

  • Mice received subcutaneous injections of recombinant human IL-10 at varying doses and time points post-surgery. Tumor necrosis factor (TNF) production was assessed after lipopolysaccharide (LPS) challenge in separate experiments.

    • Main Results:

    • Exogenous IL-10 significantly reduced TNF production by nearly 90% in LPS-challenged mice.
    • However, IL-10 administration failed to increase survival rates in mice subjected to CLP, regardless of needle gauge used for puncture.
    • IL-10 did not prevent hypothermia, increase activity, or reduce key inflammatory markers such as pulmonary neutrophil sequestration, peritoneal neutrophil recruitment, TNF, IL-6, or plasma/peritoneal fluid cytokines.

    Conclusions:

    • Exogenous IL-10 does not improve survival or reduce inflammatory parameters in the cecal ligation and puncture model of sepsis.
    • These findings suggest that IL-10 may not be a viable therapeutic agent for sepsis in this clinically relevant model.
    • Further research is needed to understand the complex role of IL-10 in sepsis pathogenesis and its potential therapeutic applications.